In some cases, an inability to balance is referred to as a symptom known as ataxia. But ataxia can also be its own condition ...

VYVDURA was also approved by the MHLW for manufacturing and marketing in January 2024 and launched in April 2024 for the treatment of generalized myasthenia gravis (gMG). In March 2024, VYVDURA was ...

Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that ...

Immunovant plans pivotal study for IMVT-1402 targeting Graves' Disease. Financial caution advised due to its limited cash ...

As families gather and laughter fills the air, for some, the holidays are a bittersweet reminder of the sacrifices caregivers ...

The festive period often brings additional stressors that can exacerbate caregiver burnout. As families gather and laughter ...

After about 10 months of being on Ozempic and working my way up to a 1-mg dose, I lost 40 pounds effortlessly. Sugar cravings ...

The market value of Zai Lab has not appreciated considerably since my "Hold" sentiment. Check out why I'm transitioning from ...

The Dangerous Intersection of Breast Cancer and Cardiovascular Disease: A Call for Improved Prevention ...

BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company that intends to change its name to BeOne Medicines Ltd., today announced the U.S. Food and Drug Administration (FDA) ...

Last year, Affinivax reported positive phase 2 results with ASP3772, which targets 24 of the common serotypes of Streptococcus pneumoniae – a bacteria which causes non-invasive illnesses like ...